Fortitude Advisory Group L.L.C. Buys 182 Shares of Abbott Laboratories (NYSE:ABT)

Fortitude Advisory Group L.L.C. grew its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 6.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,011 shares of the healthcare product maker’s stock after acquiring an additional 182 shares during […]

Related Keywords

Canada ,Raymond James ,Andreaf Wainer ,Johna Jr ,Abbott Laboratories ,Barclays ,Wealth Management ,Rappaport Reiches Capital Management ,Citigroup ,Abbott Laboratories Company Profile ,Fortitude Advisory Group ,Securities Exchange Commission ,Renaissance Investment Group ,Royal Bank ,Exchange Commission ,Alliance Wealth Advisors ,Free Report ,Wealth Advisors ,Reiches Capital Management ,Investment Group ,Drive Wealth Management ,Get Free Report ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Visit Holdingschannel ,Abbott Laboratories Daily ,Nyse Abt ,Abt ,Medical ,00282410 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,